Cargando…

A Clinical Assessment of Orphenadrine (Disipal) in the Treatment of Parkinsonism

Detalles Bibliográficos
Autores principales:	Robinson, L. R., Dick, T. H. G.
Formato:	Texto
Lenguaje:	English
Publicado:	1960
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2384361/ https://www.ncbi.nlm.nih.gov/pubmed/14437972

Ejemplares similares

Spectrofluorometric determination of orphenadrine, dimenhydrinate, and cinnarizine using direct and synchronous techniques with greenness assessment
por: Ghonim, Rana, et al.
Publicado: (2023)

Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding
por: Cheng, Mary Hongying, et al.
Publicado: (2015)

Spectrophotometric determination of tizanidine and orphenadrine via ion pair complex formation using eosin Y
por: Walash, Mohamed I, et al.
Publicado: (2011)

Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study
por: Tomic, Josip, et al.
Publicado: (2022)

Intravenous diclofenac and orphenadrine for the treatment of postoperative pain after remifentanil-based anesthesia: A double-blinded, randomized, placebo-controlled study.
por: Zeiner, Sebastian, et al.
Publicado: (2022)

Exploitation of multi-walled carbon nanotubes/Cu(ii)-metal organic framework based glassy carbon electrode for the determination of orphenadrine citrate
por: Kammoun, Ahmed K., et al.
Publicado: (2023)

A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition
por: Cheah, Kit Yee, et al.
Publicado: (2020)

Recent advances in the assessment and treatment of falls in Parkinson's disease
por: Snijders, Anke H, et al.
Publicado: (2010)

Reply to: Hypoxia treatment of Parkinson’s disease may disrupt the circadian system
por: Janssen Daalen, Jules M., et al.
Publicado: (2023)

Parkinson's Impulse‐Control Scale for the Severity Rating of Impulse‐Control Behaviors in Parkinson's Disease: A Semistructured Clinical Assessment Tool
por: Okai, David, et al.
Publicado: (2016)

An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population
por: Johnsrud, Michael, et al.
Publicado: (2021)

Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis
por: Longardner, Katherine, et al.
Publicado: (2023)

Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
por: Smulders, Katrijn, et al.
Publicado: (2012)

Lysivane in the Treatment of Parkinsonism
por: Gillhespy, R. O.
Publicado: (1953)

Clinical neurophysiology of Parkinson’s disease and parkinsonism
por: Chen, Robert, et al.
Publicado: (2022)

Clinical assessment of upper limb impairments and functional capacity in Parkinson's disease: a systematic review
por: Capato, Tamine T. C., et al.
Publicado: (2023)

Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice
por: Dashtipour, Khashayar, et al.
Publicado: (2021)

Clinical Observation of Ropinirole Hydrochloride in the Treatment of Parkinson's Disease
por: Zhang, JingZhou, et al.
Publicado: (2022)

Clinically Informed Automated Assessment of Finger Tapping Videos in Parkinson’s Disease
por: Yu, Tianze, et al.
Publicado: (2023)

Keystroke Biometrics as a Tool for the Early Diagnosis and Clinical Assessment of Parkinson’s Disease
por: Liu, Wei-Min, et al.
Publicado: (2023)

Clinical Markers of Anxiety Subtypes in Parkinson Disease
por: Broen, Martinus P. G., et al.
Publicado: (2018)

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease
por: Guridi, J., et al.
Publicado: (2012)

Swallowing Assessment in Parkinson’s Disease: Patient and Investigator Reported Outcome Measures are not Aligned
por: van Hooren, M. R. A., et al.
Publicado: (2020)

Can Digital Mobility Assessment Enhance the Clinical Assessment of Disease Severity in Parkinson’s Disease?
por: Kirk, Cameron, et al.
Publicado: (2023)

How Vacations Affect Parkinson's Disease
por: Janssen Daalen, Jules M., et al.
Publicado: (2022)

Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson’s disease
por: Reiner, Johnathan, et al.
Publicado: (2023)

An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment
por: Adam, Hussaini, et al.
Publicado: (2023)

Editorial: Measurement Tools for Clinical Assessment, Characterization and Neurorehabilitation of Parkinson's Disease
por: Rodriguez-Blazquez, Carmen, et al.
Publicado: (2021)

Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson’s Disease
por: Pons, Marie-Laure, et al.
Publicado: (2022)

Pharmacological treatment of Parkinson’s disease
por: Arabia, G
Publicado: (2010)

Risk of Parkinson's disease after tamoxifen treatment
por: Latourelle, Jeanne C, et al.
Publicado: (2010)

Parkinson’s Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization
por: Trifonova, Oxana P., et al.
Publicado: (2020)

The Neuro-Ophthalmological Assessment in Parkinson’s Disease
por: Borm, Carlijn D.J.M., et al.
Publicado: (2019)

Feasibility of a wearable inertial sensor to assess motor complications and treatment in Parkinson’s disease
por: Caballol, Nuria, et al.
Publicado: (2023)

Neuroleptic‐induced Parkinsonism: Clinicopathological study
por: Shuaib, Umar A., et al.
Publicado: (2015)

A novel scale to assess psychosis in patients with parkinson's disease
por: Ondo, William G., et al.
Publicado: (2015)

Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson’s Disease Assessed by the Unified Parkinson’s Disease Rating Scale and the Hoehn–Yahr Stage
por: Shi, Chen, et al.
Publicado: (2016)

Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
por: Fu, Rao, et al.
Publicado: (2016)

Dementia with Parkinson disease: Clinical diagnosis, neuropsychological aspects and treatment
por: Otero, Jorge Lorenzo
Publicado: (2008)

Clinical experience of comprehensive treatment on the balance function of Parkinson's disease
por: Li, Haitao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3suen1lm27rnou2oekdosru5m7